N-acetylcysteine inhibits endothelial cell invasion and angiogenesis

Laboratory Investigation

Volumn 79, Issue 9, 1999, Pages 1151-1159

  Cai, Tania ^a   Fassina, GianFranco ^a,c   Morini, Monica ^a   Aluigi, Maria Grazia ^b   Masiello, Luciana ^a   Fontanini, Gabriella ^d   D'Agostini, Francesco ^e   De Flora, Silvio ^e   Noonan, Douglas M ^a   Albini, Adriana ^a,f  

^a UNIVERSITY OF GENOA   (Italy)

^b ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; MATRIGEL;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL ACTIVATION; CELL INVASION; CHEMOPROPHYLAXIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KAPOSI SARCOMA; PHENOTYPE; PRIORITY JOURNAL;

ACETYLCYSTEINE; ANIMALS; CELL LINE; CHEMOPREVENTION; ENDOTHELIUM, VASCULAR; GELATINASES; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0032845512     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Albini A (1998). Tumor and endothelial cell invasion of basement membranes. Pathol Oncol Res 4:230-241.
2. Albini A, D'Agostini F, Giunciuglio D, Paglieri I, Balansky RM, and De Flora S (1995a). Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer 61:121-129.
3. Albini A, Barillari G, Benelli R, Gallo RC, and Ensoli B (1995b). Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 92:4838-4842.
4. Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, Noonan DM, and Stetler-Stevenson WG (1994). Angiogenic potential in vivo by Kaposi sarcoma cell-free supernatants and HIV1-tat product: Inhibition of KS-like lesions by TIMP-2. AIDS 8:1237-1244.
5. Albini A, Repetto L, Carlone S, Benelli R, Gendelman R, De Filippi P, Bussolino F, Monaco L, Soria M, and Parravicini C (1992). Characterization of Kaposi's sarcoma-derived cell cultures from an epidemic and a classic case. Int J Oncol 11:723-730.
6. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN (1987a). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245.
7. Albini A, Allavena G, Melchiori A, Giancotti F, Richter H, Comoglio PM, Parodi S, Martin GR, and Tarone G (1987b). Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell attachment site in fibronectin and a fibronectin cell surface receptor. J Cell Biol 105:1867-1872.
8. Armes J (1989). A review of Kaposi's sarcoma. Adv Cancer Res 53:73-87.
9. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A, and Stürzl M (1996). Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 149:1851-1869.
10. De Flora S, Balansky RM, Bennicelli C, Camoirano A, D'Agostini F, Izzotti A, and Cesarone CF (1995a). Mechanism of anticarcinogenesis: The example of N-acetylcysteine. In: loannidis C and Lewis DFV, editors. Mechanistic approaches to cancer, Vol 1. Hemel Hampstead, UK: Norwood Ellis, 151-203.
11. De Flora S, Cesarone CF, Balanski RM, Albini A, D'Agostini F, Bennicelli C, Bagnasco M, Camoirano A, Scatolini L, Rovida A, and Izzotti A (1995b). Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background. J Cell Biochem 22:33-41.
12. De Flora S, D'Agostini F, Masiello L, Giunciuglio D, and Albini A (1996). Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models, Int J Cancer 67:842-848.
13. Edgell CJ, McDonal CC, and Graham JB (1983). Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80:3734-3737.
14. Giunciuglio D, Benelli, Masiello L, Paglieri I, Pesarini A, Presta M, Noonan D, and Albini A (1995). Mechanisms of Kaposi's Sarcoma cell supernatant-induced vascular cell invasion, Int J Oncol 6:539-546.
15. Folkman J (1971). Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186.
16. Folkman J (1996). Fighting cancer by attacking its blood supply. Sci Am 275:150-154.
17. Folkman J (1995). Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153.
18. Heussen C and Dowdle E (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196-202.
19. Kelloff GJ, Crowell JA, Boone CW, Steel VE, Lubet RA, Greenwald P, Alberts DS, Covey J M, Doody LA, Knapp GG, Nayfield S, Parkinson DR, Prasad VK, Prorok PC, Sausville EA, and Sigman CC (1994). Clinical development plans for cancer chemopreventive agents: N-acetyl-L-cysteine. J Cell Biochem 20(Suppl.):63-73.
20. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon F, Laurie GW, and Martin GR (1986). Basement membrane complexes with biological activity. Biochemistry 25:312-318.
21. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227:680-685.
22. Liotta LA, Steeg P, and Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 6:327-336.
23. Liotta LA and Stetler-Stevenson WG (1990). Metalloproteinases and cancer invasion. Semin Cancer Biol 1:99-106.
24. Passaniti A, Taylor RM, Pili R, Quo Y, Long PV, Haney JA, Pauly RR, Grant DS, and Martin GR (1992). A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab Invest 67:519-528.
25. Pinkus R, Weiner LM, and Daniel V (1996). Role of oxidants and antioxidants in the induction of AP-1, NF-kB, and glutathione S-transferase gene expression. J Biol Chem 271: 13422-13429.
26. Stetler-Stevenson WG, Krutzsch H, Wacher M, Margulies MK, and Liotta LA (1989). The activation of human type IV collagenase proenzyme. J Biol Chem 264:1353-1356.
27. Templeton NS and Stetler-Stevenson WG (1991). Identification of a basal promoter for the human Mr 72:000 type IV collagenase and enhanced expression in a highly metastatic cell line. Cancer Res 51:6190-6193.
28. Thompson E, Nakamura S, Shima T, Melchiori A, Martin G, Salahuddin S, Gallo RC, and Albini A (1991). Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. Cancer Res 51:2670-2671.